上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1412Please respect copyright.PENANAiTBIHJ0EXv
1412Please respect copyright.PENANA7FG8CvXrLK
上集:https://www.penana.com/article/4711251412Please respect copyright.PENANAKjUTuKn6vu
1412Please respect copyright.PENANA2Bx31AJYGy1412Please respect copyright.PENANAVGp6I7CXNE
1412Please respect copyright.PENANANX2bjjsdM8
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1412Please respect copyright.PENANAobUqaioFSS
1412Please respect copyright.PENANANhgct8I0FF
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1412Please respect copyright.PENANA7XJP9FOuRD
1412Please respect copyright.PENANAMbyz7kV6w9
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1412Please respect copyright.PENANAStaOh5oVPD
1412Please respect copyright.PENANAR4CoLxfHAd1412Please respect copyright.PENANAngCamMM1Ek
1412Please respect copyright.PENANAjVXq89wEyS
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1412Please respect copyright.PENANAHh0Auqo2L3
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1412Please respect copyright.PENANAngXElZfyuT
1412Please respect copyright.PENANAoTSGm4oJ0W
忘記甚麼是Neoantigen的話,可重溫上一集。1412Please respect copyright.PENANAoZYiS91FQR
1412Please respect copyright.PENANAehy0auNxVJ
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1412Please respect copyright.PENANAxPJwOY4Dj1
1412Please respect copyright.PENANAdCS1JP8yuL
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1412Please respect copyright.PENANAY1dWY1OKqs
1412Please respect copyright.PENANABNouaFRqqS1412Please respect copyright.PENANAfKF31uZKzO
1412Please respect copyright.PENANABa3WOvJuwE
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1412Please respect copyright.PENANASkmCUf1Nld
1412Please respect copyright.PENANAqrqzEcTZ5o
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1412Please respect copyright.PENANA9BXi2gXTqn
1412Please respect copyright.PENANAEh8pQJqMQ7
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1412Please respect copyright.PENANAQFnFAuWAM11412Please respect copyright.PENANAAJHMTFMvhm
1412Please respect copyright.PENANAoRXuvWEIfX
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1412Please respect copyright.PENANAA10OEqbIX7
1412Please respect copyright.PENANAbjFKcaM5g8
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1412Please respect copyright.PENANA4x1DQVRf3J1412Please respect copyright.PENANAMgquHgAXmv
1412Please respect copyright.PENANAUc4XA5vPul
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1412Please respect copyright.PENANAoSKCDFGA9N
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1412Please respect copyright.PENANAnTOyztOQAh
1412Please respect copyright.PENANA51UQuqIoY6
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1412Please respect copyright.PENANAUhNqqnvvHt
1412Please respect copyright.PENANAI1rb0KoPDe
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1412Please respect copyright.PENANANcUBfcWH62
1412Please respect copyright.PENANAUZEg3idk4G
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1412Please respect copyright.PENANA3gj5bpq1Pr
1412Please respect copyright.PENANAfQOdgRpapE
1412Please respect copyright.PENANApVuHCfj18r
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1412Please respect copyright.PENANA2cvTZBY2Y8
1412Please respect copyright.PENANAqvc9dUMUwA
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1412Please respect copyright.PENANAefObxKyGbZ
1412Please respect copyright.PENANAFr5PqvsTQj
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1412Please respect copyright.PENANAQYcD9zkchI
1412Please respect copyright.PENANAxyscIWeWx8
Link:1412Please respect copyright.PENANAXmNEBvO9SE
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1412Please respect copyright.PENANAjbot4EDJZ8
1412Please respect copyright.PENANAskhraC7YUu
1412Please respect copyright.PENANAYzRGeOcdiN
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1412Please respect copyright.PENANAajRA6zH0eT